Immunocore Holdings Plc (IMCR)
32.70
-0.46
(-1.40%)
USD |
NASDAQ |
Feb 20, 16:00
32.70
0.00 (0.00%)
After-Hours: 20:00
Immunocore Holdings EPS Diluted (Quarterly) : -0.0035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1479 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1759M |
| Revenue (Quarterly) | 103.05M |
| Total Expenses (Quarterly) | 103.22M |
| Enterprise Value | 1.219B |
| Gross Profit Margin (Quarterly) | 98.74% |
| Profit Margin (Quarterly) | -0.17% |
| Earnings Yield | -1.79% |
| Normalized Earnings Yield | -2.475 |